Literature DB >> 17413574

FDG PET and PET/CT monitoring of autoimmune pancreatitis associated with extrapancreatic autoimmune disease.

Masatoyo Nakajo1, Seishi Jinnouchi, Masahiro Noguchi, Kimiharu Uozumi, Hiroaki Tanabe, Rie Tateno, Masayuki Nakajo.   

Abstract

We report a series of FDG PET findings of a 69-year-old male patient with autoimmune pancreatitis (AIP) associated with extrapancreatic disease. The first FDG PET revealed diffuse uptake of FDG in AIP and retroperitoneal fibrosis (RF). The second FDG PET after cessation of steroid treatment indicated subsiding of disease activity in AIP, continuous disease activity in RF, and new extrapancreatic lesions, including enlargement of a right salivary gland, nephritis, and lymphadenopathy. The last FDG PET under steroid treatment revealed reduced FDG uptake in the above abnormal FDG uptake lesions. A series of these FDG PET findings suggest the usefulness of FDG PET for the diagnosis and monitoring of AIP associated with extrapancreatic autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17413574     DOI: 10.1097/01.rlu.0000257295.12017.ab

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  6 in total

1.  [¹⁸F]FDG-PET/CT in patients affected by retroperitoneal fibrosis: a bicentric experience.

Authors:  Francesco Bertagna; Giorgio Treglia; Lucia Leccisotti; Giovanni Bosio; Federica Motta; Alessandro Giordano; Raffaele Giubbini
Journal:  Jpn J Radiol       Date:  2012-03-16       Impact factor: 2.374

2.  Retroperitoneal fibrosis as a cause of positive FDG PET/CT.

Authors:  Amar Mehta; Todd M Blodgett
Journal:  J Radiol Case Rep       Date:  2011-07-01

3.  FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations.

Authors:  Koji Murakami
Journal:  World J Clin Oncol       Date:  2011-05-10

4.  The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions.

Authors:  Masatoyo Nakajo; Seishi Jinnouchi; Yoshihiko Fukukura; Hiroaki Tanabe; Rie Tateno; Masayuki Nakajo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-08-23       Impact factor: 9.236

Review 5.  The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases.

Authors:  Andor W J M Glaudemans; Erik F J de Vries; Filippo Galli; Rudi A J O Dierckx; Riemer H J A Slart; Alberto Signore
Journal:  Clin Dev Immunol       Date:  2013-08-21

6.  Clinical Utility of FDG PET/CT in Patients with Autoimmune Pancreatitis: a Case-Control Study.

Authors:  Mei-Fang Cheng; Yue Leon Guo; Ruoh-Fang Yen; Yi-Chieh Chen; Chi-Lun Ko; Yu-Wen Tien; Wei-Chih Liao; Chia-Ju Liu; Yen-Wen Wu; Hsiu-Po Wang
Journal:  Sci Rep       Date:  2018-02-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.